Related Experiment Video
Updated: Jun 2, 2026
11:36
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Leptin does not directly affect CNS serotonin neurons to influence appetite
Daniel D Lam1, Gina M Leinninger, Gwendolyn W Louis
1Department of Pharmacology, University of Cambridge, UK.
Cell Metabolism
|May 3, 2011
Summary
Leptin does not directly affect serotonin neurons to control appetite. This study found that serotonin depletion does not impact leptin's appetite-suppressing effects in the brain.
Area of Science:
- Neuroscience
- Endocrinology
- Metabolism
Background:
- Serotonin (5-HT) and leptin are key regulators of energy balance.
- Understanding their interaction in the central nervous system (CNS) is crucial for appetite control.
Purpose of the Study:
- To investigate the mechanisms of leptin interaction with CNS serotonin pathways influencing appetite.
- To determine if leptin directly modulates serotonin neuron activity.
Main Methods:
- Examined leptin receptor (LepRb) expression in dorsal raphe (DR) serotonin neurons.
- Assessed leptin's effect on DR neuron activity in vivo.
- Investigated the impact of serotonin depletion on leptin's anorectic effects.
- Utilized neuron-specific LepRb inactivation via the serotonin transporter-cre (Sert(cre)) allele in mice.
Main Results:
- Serotonin neurons in the DR do not express functional leptin receptors (LepRb).
- Leptin does not alter the activity of DR serotonin neurons.
- Serotonin depletion does not impair the appetite-suppressing effects of leptin.
- Neuron-specific LepRb inactivation in mice did not affect body weight or adiposity.
Conclusions:
- Leptin does not directly influence serotonin neurons to regulate appetite.
- The anorectic effects of leptin are not mediated through direct modulation of 5-HT neuron function.
More Related Videos
Related Concept Videos
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...